Research Hub Banner

    Select a Company

    Me Cure Industries Plc

    Sante Pharmacie et biotechnologie
    11.10 NGN     0 / 0%
    As of 24-Jun-2025

    Cours veille

    11.10

    Volume

    5,686,097

    Valeur Transactions

    NGN 56,926,451.90

    Deals

    152

    Actions en Circulation

    4,000.00 mln

    Capitalisation

    NGN 44,400.00 mln


    Loading Chart ...


    52W RANGE

    7.35 - 13.90

    1W

    --

    1M

    --

    3M

    -1.33%

    YTD

    -20.14%

    1Y

    +15.99%


    loading...

    About the company

    Me Cure is a therapeutics company in the pharmaceutical industry in Lagos, Nigeria. For more than a decade, the company has tapped the power of new technology and innovation to advance the practice of medicine. Products: OTC Medicines, Branded Generics and Dietary Supplements.


    Site web
    www.mecure.com
    info@mecure.com


    SYMBOL
    MECURE    		 ISIN
    NGMECURE0006
    Création
    2005    		 Cotation
    2023
    Téléphone
    -    		 FAX
    -

    Me Cure House, Plot 6, Block H, Apapa Oshodi Expressway, Oshodi, Lagos. Nigeria

    Competitors

    Neimeth International Pharmaceuticals Plc4.47+9.83%
    Fidson Healthcare Plc43.10+5.25%
    Pharma-Deko Plc1.83--
    Juli Plc10.30--
    May & Baker Nigeria Plc15.95-0.31%

    MECURE | Declaration of dividend 4 mars 2025
    MECURE | Notice of board meeting14 févr. 2025
    MECURE | Notice of closed period 6 janv. 2025
    MECURE | Share dealing 8 nov. 2024
    MECURE | Share dealing 8 nov. 2024
    MECURE | Notice of board meeting23 oct. 2024
    MECURE | Acquisition of ten Percent Equity Stake 6 oct. 2024
    MECURE | Notice of board meeting 5 août 2024
    MECURE | AGM resolutions 8 juil. 2024
    MECURE | Notice of annual general meeting 6 juin 2024
    MECURE | Appointment of independent directors16 mai 2024
    MECURE | Correction of 2023 AFS29 avril 2024
    MECURE | Declaration of dividend 6 mars 2024
    MECURE | Rescheduled of board meeting27 févr. 2024
    MECURE | Notice of board meeting15 févr. 2024

    Analyse & Recherche

    NGX | Nigerian Exchange - Monthly Equities Report - January 2025 : Upbeat start to the year across global & local markets 5 févr. 2025
    NGX | Nigeria Telecoms outlook - Tariff hike portends stronger earnings for operators23 janv. 2025
    NGX | Nigeria: 2025 Macroeconomic Outlook : Pressure to Plateau31 déc. 2024
    NGX | Afrinvest Weekly Stock Recommendation - October 28, 202428 oct. 2024
    NGX | Nigerian Exchange - Monthly Equities Report - September 2024 : Global equities rally on monetary policy decision; Energy stocks improve sentiment in local equities 9 oct. 2024
    NGX | Nigerian Cement mid-year outlook - Public demand to boost topline amid cost pressures 4 oct. 2024
    NGX | Nigerian Exchange - Monthly Equities Report - August 2024 : US Fed’s dovish signaling excites global markets; Cement sector drags local equities 5 sept. 2024
    NGX | Weekly Roundup and Stock Recommendations - August 26, 202426 août 2024
    NGX | Nigerian Exchange - Monthly Equities Report - July 2024 : Rate cut expectation drives rotation into small caps; bearish bias in local equities 7 août 2024
    NGX | Nigerian Exchange - Monthly Equities Report - April 2024 : The bears dominate performance across markets 9 mai 2024

    Rapports Annuels & Financiers

    Annual Report 2023
    Annual Report 2022
    Annual Report 2021
    Annual Report 2020
    Annual Report 2019
    Annual Report 2018

     

    0.15 NGN 3 juil. 2024

    Login